Trials / Completed
CompletedNCT00711321
Long-term Safety and Tolerability of AFFITOPE AD02
Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD02 Applied During AFFiRiS 002
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (actual)
- Sponsor
- Affiris AG · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the long-term tolerability and -safety of AFFITOPE AD02 applied during AFFiRiS 002
Conditions
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2008-07-08
- Last updated
- 2010-05-27
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00711321. Inclusion in this directory is not an endorsement.